The newborn screening market is predicted to rise at a stellar growth rate for the 2020 – 2030 forecast period. Rising prevalence of newborn disorders, availability of neonatal intensive care facilities, and favorable reimbursement scenarios are spelling growth in the newborn screening market.
Key parameters based on which the newborn screening market is divided are product, technology, and region.
The report provides an all-important analysis of the newborn screening market for the 2020 – 2030 forecast period covering demand dynamics, key segments, and competitive landscape.
Grab an exclusive PDF Brochure of this report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=7355
Newborn Screening Market – Competitive Landscape
The newborn screening market features an intensely competitive vendor landscape with the presence of several large medical devices manufacturing companies in the fray. Product innovation and development of existing products is the key focus of keen players in the newborn screening market to consolidate their position. These players are investing heavily in R&D and capital investments for such initiatives. M&As and strategic collaborations is also what keen players are engaged in to garner higher revenue share in the newborn screening market.
Prominent players in the newborn screening market include;
- Bio-Rad Laboratories
- Danaher Corporation
- Chromsystems Instrumnets & Chemicals GmbH
- Trivitron Healthcare
- Parseq Lab
Buy this Premium Report @ https://www.tmrresearch.com/checkout?rep_id=7355<ype=S
Newborn Screening Market – Key Drivers
The vast rise in prevalence of newborn disorders that requires a combination of treatment, including screening is creating opportunities in the newborn screening market. Manufacturers of newborn screening are making intense efforts to develop avant-garde screening devices that feature all-in-one capabilities.
Newborn screening usually involves detection of hearing, hormonal, congenital heart diseases, and metabolic disorders that can be treated if diagnosed early.
In the U.S, during 2015 – 2017, the statistics of newborn disorders was 34 for every 10,000 live births, according to the US CDC. Going by these numbers, nearly 12,900 infants are expected to be detected with a disorder each year, adds the US CDC.” Hearing loss, sickle-cell disease, cystic fibrosis, and congenital hypothyroidism are most prevalent among newborns and infants that requires screening.
The high prevalence of congenital heart disease among newborns that requires screening underscores growth in the newborn screening market. According to the Indian Pediatric Academy, 9 out of each 1,000 births are identified with congenital heart disease in India. This translated to more than 200,000 children that are born with congenital heart diseases each year in the country.
Another statistics projected for congenital heart disease by BabysFirstTest.org – an organization that receives support from the US Health Resources and Services Administration – critical congenital heart disease is likely to affect two out of each 1,000 births each year in the U.S. in the future.
Newborn Screening Market – Regional Landscape
Asia Pacific is a key region in the overall newborn screening market owing to high birth rates and increasing disposable incomes in emerging economies of the region. According to statistics of the United Nations Children’s Fund, India registers 25 million births each year, which is nearly one-fifth of the total childbirths each year globally.
Get Table of Content of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=7355
The modernization of healthcare facilities, availability of technologically advanced medicine, and rising disposable incomes in India is opening the expanse of newborn screening. This is creating opportunities in the newborn screening market of Asia Pacific.
Besides this, China accounts for significant revenue to the newborn screening market in Asia Pacific. In the past 35 years, China has recorded tremendous demand for newborn screening for the detection of newborn disorders. For example, in 2017, the overall rate of PKU and CH screening crossed 96%.
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.